WATERTOWN, Mass. (BUSINESS WIRE) SQZ Biotechnologies Company (NYSE: SQZ), focused on unlocking the full potential of cell therapies for multiple therapeutic areas, today announced that Armon Sharei, Ph.D., Chief Executive Officer and Founder at SQZ Biotechnologies, will present at the H.C. Wainwright 24th Annual G.
SQZ Biotechnologies Announces Leadership Transition streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Granted FDA Fast Track Designation for APC Clinical CandidatePublished Comprehensive Preclinical Research on SQZ® TAC Platform in Frontiers in ImmunologyPresented First SQZ® Point-of-Care (POC) Manufacturing System Performance Data; Initial Clinical Use Planned for SQZ® TAC Celiac Disease Program with IND Submission.
SQZ Biotechnologies Reports Second Quarter 2022 Financial Results and Recent Portfolio Updates streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Experienced Biotech Leader and Capital Markets Professional Elevated to Chief Financial Officer from Chief Business Officer RoleAppointment Effective July 11, 2022WATERTOWN, Mass. (BUSINESS WIRE) SQZ Biotechnologies (NYSE: SQZ), focused on unlocking the full potential of cell therapies for multiple therapeutic are.